Child and adolescent myopia has emerged as a prominent public health issue in China, characterized by trends of earlier onset and increasing severity. The prevention and control of myopia in children and adolescents present substantial challenges to public health. Driven by robust national policies, several distinctive technical guidance documents have been issued in recent years within relevant professional domains. Nevertheless, notable gaps persist in the quantification of evidence quality and intervention efficacy, multidimensional combination strategies, and the provision of specific operational guidance for clinical and public health practice. In response, the Visual Health (Myopia Prevention and Control) Study Group of the Child and Adolescent Health Branch of the Chinese Preventive Medicine Association convened a multidisciplinary panel comprising clinical experts, public health specialists, and methodologists engaged in clinical practice guideline development. Adhering rigorously to international standards for guideline development, the panel formulated eight clinical questions spanning three core dimensions, including environmental regulation, behavioral modification, and pharmacological/optical correction, and subsequently developed eight corresponding evidence-based recommendations. These recommendations aim to provide more precise and systematic evidence-based guidance for myopia prevention and control in clinical and public health practice, thereby enhancing the scientific validity and effectiveness of myopia management efforts in Chinese children and adolescents.